GlassScriptPhysician profile
Kurt G Meissner
NPI 1164427449
$1,369.50
in general payments reported to CMS, 2019-2025
20 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $165 · 2021: $70.14 · 2022: $180 · 2023: $184 · 2024: $34.04 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $389.36 | 2019-2022 | |
| Axonics, INC. | $215.15 | 2022-2024 | Axonics |
| Astellas Pharma US INC | $133.28 | 2019-2020 | |
| Intuitive Surgical, INC. | $126.05 | 2019 | |
| Caldera Medical, INC | $107.72 | 2025 | |
| Sumitomo Pharma America, INC. | $76.35 | 2023-2025 | Gemtesa, Orgovyx |
| Dornier Medtech America, INC | $41.52 | 2020 | |
| Coopersurgical, INC. | $41.48 | 2020 | |
| Novartis Pharmaceuticals Corporation | $32.38 | 2025 | |
| Janssen Biotech, INC. | $29.00 | 2019-2020 | |
| Blue Earth Diagnostics | $28.77 | 2019 | |
| Boston Scientific Corporation | $26.33 | 2025 | Axonics |
| Urovant Sciences INC | $21.40 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.33 | 2020 | |
| Medtronic, INC. | $17.46 | 2025 | Interstim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $14.03 | 2019 | |
| Agiliti Surgical, INC. | $13.31 | 2019 | |
| Abbvie INC. | $13.20 | 2019 | |
| Endo Pharmaceuticals INC. | $11.80 | 2019 | |
| Antares Pharma, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Meissner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.